|
| 36698840 | 1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model. | Front Med (Lausanne) | 2023 |
| 37839622 | Health diplomacy in action: The cancer legacy of the Good Friday Agreement. | J Cancer Policy | 2023 |
| 37608772 | Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer | J Pathol | 2023 |
| 37608771 | Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. | J Pathol | 2023 |
| 37377210 | SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer. | Cell Cycle | 2023 |
| 37105783 | Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer. | Eur Urol Focus | 2023 |
| 34379360 | PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. | J Pathol Clin Res | 2022 |
| 35834277 | Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response. | Cancer Res | 2022 |
| 35434898 | Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects. | Cancer Med | 2022 |
| 35312747 | Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer. | Clin Chem | 2022 |
| 35332319 | Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. | Nat Rev Cancer | 2022 |
| 35114091 | Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer. | Expert Opin Ther Targets | 2022 |
| 35055387 | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. | J Pers Med | 2022 |
| 35109796 | Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. | BMC Cancer | 2022 |
| 35260379 | Plant-derived cannabinoids as anticancer agents. | Trends Cancer | 2022 |
| 33122343 | Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer. | Clin Cancer Res | 2021 |
| 34857211 | Association of circulating short chain fatty acid levels with colorectal adenomas and colorectal cancer. | Clin Nutr ESPEN | 2021 |
| 34380638 | The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8. | Clin Cancer Res | 2021 |
| 34454584 | Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer. | Clin Epigenetics | 2021 |
| 33937029 | The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development. | Front Oncol | 2021 |
| 33983492 | The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer. | Breast Cancer Res Treat | 2021 |
| 34060548 | Feature fusion of Raman chemical imaging and digital histopathology using machine learning for prostate cancer detection. | Analyst | 2021 |
| 34117103 | Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer. | J Clin Pathol | 2021 |
| 34090143 | Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors. | Eur J Cancer | 2021 |
| 32510287 | Advances in tissue-based imaging: impact on oncology research and clinical practice. | Expert Rev Mol Diagn | 2020 |
| 33564664 | Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. | Biomed Hub | 2020 |
| 32000564 | Evaluating liquid biopsies for methylomic profiling of prostate cancer. | Epigenetics | 2020 |
| 31641007 | Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study. | Clin Cancer Res | 2020 |
| 32054850 | Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma. | Cell Death Dis | 2020 |
| 32041094 | Clinical Decision Support Systems in Breast Cancer: A Systematic Review. | Cancers (Basel) | 2020 |
| 33066609 | Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. | Cancers (Basel) | 2020 |
| 33260953 | Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer. | Cancers (Basel) | 2020 |
| 33004351 | A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer. | Cancer Res | 2020 |
| 32927694 | The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology. | Life (Basel) | 2020 |
| 32555399 | Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer. | Sci Rep | 2020 |
| 32503808 | The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype. | Cancer Res | 2020 |
| 32194855 | An EPR Strategy for Bio-responsive Fluorescence Guided Surgery with Simulation of the Benefit for Imaging. | Theranostics | 2020 |
| 32369904 | Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer Patients. | Cancers (Basel) | 2020 |
| 32316111 | Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells. | Antioxidants (Basel) | 2020 |
| 30368132 | PEGylated BF<sub>2</sub>-Azadipyrromethene (NIR-AZA) fluorophores, for intraoperative imaging. | Eur J Med Chem | 2019 |
| 31588261 | RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery. | Chem Sci | 2019 |
| 31439579 | POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients. | Clin Cancer Res | 2019 |
| 31384312 | Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial. | Ther Adv Med Oncol | 2019 |
| 31554901 | Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects. | Mucosal Immunol | 2019 |
| 31409615 | BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer. | Clin Cancer Res | 2019 |
| 31235775 | Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents. | Sci Rep | 2019 |
| 31217905 | 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours. | Oncotarget | 2019 |
| 30801051 | epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer. | JCO Precis Oncol | 2019 |
| 30768761 | Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate. | Proteomics Clin Appl | 2019 |
| 30798618 | Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes. | Circ Heart Fail | 2019 |